BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 1268825)

  • 1. Immune response of BALB/c X DBA/2F1 mice to a tumor allograft during pyran copolymer-induced tumor enhancement.
    Schultz RM; Woods WA; Mohr SJ; Chirigos MA
    Cancer Res; 1976 May; 36(5):1641-6. PubMed ID: 1268825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of a tumor allograft in BALB/c x DBA/2 F1 mice by pyran copolymer.
    Mohr SJ; Chirigos MA; Fuhrman F; Smith G
    Cancer Res; 1976 Apr; 36(4):1315-9. PubMed ID: 1260757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor suppression by pyran copolymer: correlation with production of cytotoxic macrophages.
    Harmel RP; zbar B
    J Natl Cancer Inst; 1975 Apr; 54(4):989-92. PubMed ID: 1127729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyran (MVE-5) reverses the inhibition of macrophage receptors for cytophilic antibody induced by soluble immune complexes.
    Rao VS; Mitchell MS
    J Biol Response Mod; 1983; 2(1):67-80. PubMed ID: 6606020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo modulation of myelopoiesis and immune functions by maleic anhydride divinyl ether copolymer (MVE-2) in tumor-free and MBL-2 tumor-bearing mice treated with cyclophosphamide.
    Schlick E; Ruffmann R; Chirigos MA; Welker RD; Herberman RB
    Cancer Res; 1985 Mar; 45(3):1108-14. PubMed ID: 3871661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and serum involvement in protection against Friend leukemia virus.
    Schuller GB; Morahan PS
    Cancer Res; 1977 Nov; 37(11):4064-9. PubMed ID: 908040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pyran copolymer on activation of murine macrophages: evidence for incomplete activation by use of functional markers.
    Adams DO; Johnson WJ; Marino PA; Dean JH
    Cancer Res; 1983 Aug; 43(8):3633-7. PubMed ID: 6861134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage involvement in the protective effect of pyran copolymer against the Madison lung carcinoma (M109).
    Schultz RM; Papamatheakis JD; Luetzeler J; Ruiz P; Chirigos MA
    Cancer Res; 1977 Feb; 37(2):358-64. PubMed ID: 832262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific potentiation of L1210 vaccine by pyran copolymer.
    Mohr SJ; Chirigos MA; Smith GT; Fuhrman FS
    Cancer Res; 1976 Jun; 36(6):2035-9. PubMed ID: 1268855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of adriamycin and cyclophosphamide treatment on induction of macrophage cytotoxic function in mice.
    Stoychkov JN; Schultz RM; Chirigos MA; Pavlidis NA; Goldin A
    Cancer Res; 1979 Aug; 39(8):3014-7. PubMed ID: 455286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathology of the host response to Lewis lung carcinoma: modulation by pyran.
    Snodgrass MJ; Morahan PS; Kaplan AM
    J Natl Cancer Inst; 1975 Aug; 55(2):455-62. PubMed ID: 1159827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maleic vinyl ether activation of murine macrophages against lung-metastasizing tumors.
    Loveless SE; Munson AE
    Cancer Res; 1981 Oct; 41(10):3901-6. PubMed ID: 7285000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage-mediated natural cytotoxicity of dimethyl sulfoxide-treated Friend erythroleukemia cells.
    Hsu KH; Friedman H
    J Natl Cancer Inst; 1985 Jul; 75(1):105-10. PubMed ID: 3859684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inability of anti-asialo-GM1 and 2-chloroadenosine to abrogate maleic anhydride-divinyl ether-induced resistance against experimental murine lung carcinoma metastases.
    Schultz RM; Tang JC; DeLong DC; Ades EW; Altom MG
    Cancer Res; 1986 Nov; 46(11):5624-8. PubMed ID: 3756909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage cytotoxicity in the mouse immune response against a skin allograft.
    Dimitriu A; Dy M; Thomson N; Hamburger J
    J Immunol; 1975 Jan; 114(1 Pt 1):195-9. PubMed ID: 122985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of resistance to MOPC-315 plasmacytoma after intralesional and intraperitoneal melphalan therapy of tumor-bearing BALB/c mice. II. Enhancement of in vitro cell-mediated cytotoxicity by combined chemotherapy-immunotherapy.
    Adler A; Keisari Y; Ofir R
    J Natl Cancer Inst; 1985 Feb; 74(2):429-36. PubMed ID: 3856051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of maleic anhydride-divinyl ether copolymers on experimental M109 metastases and macrophage tumoricidal function.
    Pavlidis NA; Schultz RM; Chirigos MA; Luetzeler J
    Cancer Treat Rep; 1978 Nov; 62(11):1817-22. PubMed ID: 728899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OK-432-mediated augmentation of antitumor immunity and generation of cytotoxic T lymphocytes.
    Ujiie T
    Jpn J Exp Med; 1987 Apr; 57(2):103-15. PubMed ID: 3499533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
    Liepins A; Nowicky JW
    Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of the mechanisms for the induction of in vivo tumor immunity. IV. Enhancement of the in vitro generation of secondary cell-mediated cytotoxic response by normal peritoneal macrophages and their culture supernatants.
    Igarashi T; Rodrigues D; Ting CC
    J Immunol; 1979 Apr; 122(4):1519-27. PubMed ID: 156217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.